Researchers have found a new way to reactivate fetal hemoglobin without the need for gene-editing therapy, according to a new study.
Disc Medicine will be enrolling 24 adults with SCD in its newly launched trial testing DISC-3405 at three doses for easing ...
Columnist Oluwatosin Adesoye encourages medical professional to be more mindful about the care they provide to sickle cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback